Mankind Pharma & SpiceJet Collaboration Elevates Healthcare Innovation and Awareness.

In an exciting development in the healthcare and aviation sectors, Mankind Pharma, a global pharmaceutical firm, has joined hands with SpiceJet, one of India's leading domestic airlines, to boost brand awareness and highlight its commitment to healthcare excellence. The collaboration involves displaying Mankind's logo on SpiceJet planes, not only showcasing the brand's journey and vision but also emphasizing Mankind Pharma's dedication to innovation and raising industry standards.

This partnership signifies a significant step in advancing Mankind Pharma's mission of providing international quality medicines to all. The company has taken a pioneering step by introducing 120 DMF (Drug Master File) quality API medicines in the Indian market, adhering to stringent international standards.

Rajeev Juneja, Vice Chairman, and Managing Director of Mankind Pharma, expressed his enthusiasm for the collaboration, stating, "At Mankind Pharma, our continuous endeavor has been to improve lives through groundbreaking healthcare solutions. Our goal is to enable access to international quality API medicines for everyone. This has led to the introduction of 120 DMF quality API in our medicines."

DMF-grade API medicines in the USA comply with the rigorous quality, safety, and effectiveness standards set by the USFDA. The Drug Master File (DMF) contains comprehensive information on an Active Pharmaceutical Ingredient (API) or raw material used in medicines. It provides detailed data on manufacturing processes, stability, quality, packaging, purity, and impurity profiles, ensuring that medicines meet international quality standards.

The primary objective of this campaign is to raise awareness about DMF-grade API medicines and the importance of affordable yet high-quality healthcare. Mankind Pharma aims to reach a broader audience and enhance its brand image through captivating airport promotions and media spotlights. Leveraging this partnership, the company intends to create a lasting impression on consumers, reinforcing its position as a trusted pharmaceutical company in the Indian industry.

Debojo Maharshi, Chief Business Officer of SpiceJet, congratulated Mankind Pharma on their vision of introducing 120 DMF quality API medicines in India, underscoring their commitment to pharmaceutical excellence. He mentioned, "SpiceJet’s unique flying billboards have become an integral part of promotions for various top brands, and we are delighted to offer this innovative and effective medium to Mankind Pharma once again. We look forward to a long and fruitful association with them."

Two SpiceJet planes featuring Mankind's vision of providing international quality API medicines took flight on September 21st. This initiative aligns with one of the core focuses of the G20 India Presidency's health initiatives, Universal Healthcare. SpiceJet's extensive network provides excellent visibility and reach, making it an ideal platform to raise awareness about Mankind's vision. This collaboration strategically utilizes SpiceJet's wide customer base and market presence to effectively communicate Mankind Pharma's dedication to excellence in medicine production.

The collaboration between Mankind Pharma and SpiceJet is not only a significant step towards promoting healthcare innovation but also a testament to their commitment to ensuring that quality healthcare is accessible to all.

As the partnership takes flight, it promises to soar to new heights in both the pharmaceutical and aviation industries, leaving a lasting impression on passengers and industry stakeholders alike.